MOMM Diagnostics GmbH is a privately held Swiss startup that is revolutionizing the field of diagnostics with its game-changing rapid diagnostic test technology. With our focus on developing the préXclude rapid preeclampsia test, we are poised to make a significant impact on maternal healthcare. We welcome potential investors who share our vision and are interested in advancing the field of diagnostics. Join us on our mission to improve patient outcomes and transform the way healthcare is delivered.
MOMM has received support from the following organizations: